Results 111 to 120 of about 65,460 (210)
The elucidation of molecular mechanisms in systemic mastocytosis [PDF]
, 2018 Mastocytosis, one of the subcategories of myeloproliferative neoplasms, results from a colonel, neoplastic proliferation of morphologically and immunophenotypically abnormal mast cells which accumulate primarily in the skin and bone marrow. Prevalence
Mcmullen, Amy Anne
core
Two patients with osteoporosis: initial presentation of systemic mastocytosis
, 2008 In two patients with osteoporosis, systemic mastocytosis ultimately turned out to be the underlying disease. Both patients had a history of anaphylactic reactions caused by wasp stings but did not have any skin or other symptoms.
Verhage, Albert H. +3 more
core +1 more source
Plasma Protein Profiling to Discern Indolent from Advanced Systemic Mastocytosis
Mastocytosis is a heterogeneous disorder characterized by abnormal mast cell accumulation, in which the clinical severity may be explained by distinct molecular mechanisms.
Nilsson, GP +29 more
core +1 more source
, 2016 International audienceBackground: Telangiectasia macularis eruptiva perstans (TMEP) has not been fully characterized.Objective: We sought to estimate the frequency and clinical characteristics of TMEP in a cohort of adult patients with cutaneous ...
Mailhol, Claire +15 more
core +1 more source
Plenary Abstracts Session & Oral Presentations
HemaSphere, Volume 10, Issue S1, June 2026.
wiley +1 more source
Interferon-α treatment in systemic mastocytosis
, 2011 Patients with systemic mastocytosis are rare, constitute a heterogeneous clinical entity and some may not require treatment until long after diagnosis.
Bjerrum, Ole Weis
core
Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis
, 2016 BACKGROUND Advanced systemic mastocytosis comprises rare hematologic neoplasms that are associated with a poor prognosis and lack effective treatment options.
Reiter, Andreas +17 more
core +1 more source